ainewsblitz.com

Breaking

Roche Taps Recursion's AI to Hunt New Brain-Disease Targets in Neuroscience Push

Roche Taps Recursion's AI to Hunt New Brain-Disease Targets in Neuroscience Push
  • Healthcare
  • Foundation Models
  • Sales & Business

Roche is using Recursion Pharmaceuticals' artificial intelligence platform to uncover previously unknown biological targets for brain diseases such as Alzheimer's and Parkinson's, part of a broader bet that AI can reduce the high failure rate of drug trials by discovering entirely new biology.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,934 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year